Vanda Pharmaceuticals To Present Data on VEC-162 at SLEEP 2007, the
Annual Meeting of the Associated Professional Sleep Societies
ROCKVILLE, Md., June 08, 2007 /PRNewswire-FirstCall/ --
VandaPharmaceuticals Inc. announced today that Dr. Tom Roth, Director ofthe Henry Ford Sleep Disorders and Research Center in Detroit, MI,will deliver an oral presentation on recent Phase III clinicaltrial results for VEC-162,
Vanda's balanced melatonin (MT1/MT2)receptor agonist, at SLEEP 2007, the 21st annual meeting of theAssociat...
Vanda Pharmaceuticals to Present Data on Iloperidone at the 2007
American Psychiatric Association Annual Meeting
ROCKVILLE, Md., May 18, 2007 /PRNewswire-FirstCall/ --
VandaPharmaceuticals Inc. announced today that it will present fourposters on iloperidone at the 160th American PsychiatricAssociation (APA) annual meeting which will be held at the SanDiego Convention Center in San Diego, CA, from May 19 through May24, 2007. The following posters will be presented on May 22, 2007, 12:00to 2:0...